Liquid Nanoparticles for Nanocatalytic Cancer Therapy
Advanced Materials · 2023-11 · 35 (48)
DOI: 10.1002/adma.202306469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 22.10.2023. Verfasst von Ruizhi Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Shanghai East Hospital, Pudong Health Bureau of Shanghai, Shanghai Science and Technology Program.
Abstract (Originalsprache)
Nanotechnology is revolutionizing cancer therapy, and catalyzes the emerging of ion‐involved cancer‐therapeutic modality, which unfortunately suffers from undesirable nanocarriers for efficient intracellular ion delivery. To radically extricate from this critical issue, the glutathione (GSH)‐responsive organosilica network is employed to lock the liquid drops at the nanoscale via a general bottom‐up strategy to achieve the systemic delivery of “ion drugs”. In this work, a sulfate radical generation donor (Na 2 S 2 O 8 ), as a paradigm “ion drug”, is entrapped into this liquid nanoparticle for efficiently delivering to the tumor region. After further surface engineering with pH‐responsive tannic acid‐Fe 2+ framework, these liquid nanoparticles achieve tumor‐microenvironmental pH/GSH‐dual responsive ion release (Fe 2+ /Na + /S 2 O 8 2− ) after reaching the tumor sites, where the Fe 2+ further triggers S 2 O 8 2− to generate toxic •SO 4 − and •OH, effectively executing cancer cell ferroptosis (Fe 2+ , reactive oxygen species—ROS) and pyroptosis (Na + , ROS). Such a tumor‐responsive/specific liquid nanoplatform is highly instructive for further ion‐mediated nanomedicine and disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, P. R. China.
- Department of Emergency, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P. R. China.
- Education Institute, Tongji University School of Medicine, Tongji University Cancer Center, Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment, National Clinical Research Center of Interventional…
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute of Shanghai University, Wenzhou, Zhejiang, 325088, P. R. China.
ORCID-Profile: Yu Chen
Förderung
- Shanghai East Hospital
- Pudong Health Bureau of Shanghai
- Shanghai Science and Technology Program
- Basic Research Program of Shanghai Municipal Government
- Shanghai Education Development Foundation and Shanghai Municipal Education Commission
- Innovative research team of high-level local universities in Shanghai
- National Natural Science Foundation of China
- Important Weak Subject Construction Project of Shanghai Pudong New Area Health Commission
Zitieren
APA
Hu, R., Chen, X., Li, Z., Zhao, G., Ding, L., Chen, L., Dai, C., Chen, Y., & Zhang, B. (2023). Liquid Nanoparticles for Nanocatalytic Cancer Therapy. Advanced Materials, 35(48). https://doi.org/10.1002/adma.202306469
Vancouver
Hu R, Chen X, Li Z, Zhao G, Ding L, Chen L, et al. Liquid Nanoparticles for Nanocatalytic Cancer Therapy. Advanced Materials. 2023;35(48). doi:10.1002/adma.202306469
BibTeX
@article{Hu2023,
author = {Hu, Ruizhi and Chen, Xiaoying and Li, Zhifang and Zhao, Guojun and Ding, Li and Chen, Liang and Dai, Chen and Chen, Yu and Zhang, Bo},
title = {Liquid Nanoparticles for Nanocatalytic Cancer Therapy},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {48},
doi = {10.1002/adma.202306469}
}
EUVIMED